Call
+918447748545

Published on: Nov 13, 2020
2 minute read
By: Dr Rajan ( Medical Second Opinion Cell)

What Are Some Common Side Effects Of The COVID-19 Vaccine?

COVID Vaccine, the Pfizer update

On Monday Pfizer announced to the world the vaccine, once it has been developing with Germany's BioNTech, was found to be more than 90?fective. If this is substantiated, it may be possible for countries to receive the vaccine before the end of the year.

The Vaccine is an mRNA Vaccine, a novel method that introduces viral RNA into the body via a viral coat. The vaccine is incorporated into the person's cell, where the viral RNA is read and viral proteins are produced, including the coronavirus coat proteins. As the body reads and recognizes these proteins, it produces antibodies against these viral proteins and activates immune T cells against the virus.

The Pfizer results are based of a phase 3 clinical trial with 43, 538 participants with a diverse background. In this trial, the participants were split between those receiving a vaccine, and those who received a placebo with no effect. The vaccine is administered in two parts, with a 90?ficacy obtained 7 days after the second dose. This would mean a person is vaccinated just 28 days after the initial vaccination.

The FDA usually looks for a minimum 50?ficacy in vaccination when approving new vaccines. It may surprise you that the annual flu jab is also estimated to be 50?fective. The data from Pfizer was verified by an external, independent Data Monitoring Committee. It used data from 94 patients enrolled in the trial and subsequently developed COVID. It is from this groupset that 90% of efficacy is obtained. This is not the final data analysis, and further publications are expected in late November, with a potential FDA Emergency Use Authorisation approval if the data continues to show promise.

If approved, Pfizer has the ability to make 50 million shots before the end of the year, and 1.3 billion by the end of 2021. Many countries are clamoring for their fair share of these limited resources; the US has already negotiated 200m shots, UK 50m, and Germany (one of the major financers for the Pfizer vaccine) over 300m for European Countries.

We should emphasize that rapid vaccine development on this scale at this speed was unheard of prior to COVID. Usually, the animal studies for vaccines can take 1-2 years. In that time Pfizer and others have managed phase 1-3 clinical trials in humans, something that usually takes upwards of 10 years.

There are many unanswered questions that remain from this information.

How safe is the vaccine? Whilst safety information was not published, overall the vaccine appears to have minimal side effects. This is particularly difficult to state however since mRNA vaccines have never been used in people before.
Does the vaccine prevent transmission? In theory, yes. If you are immunized the replication of the virus should be limited significantly, so the number of viruses in each cough will be much lower. However, we do not have data to prove that there is no transmission, but that is also because we have very little data overall.
How long does the protection last? This is a very critical question. The 90?fectiveness rate was calculated just 7 days after the second shot, but it is likely this will change as data is collected over the long term. Some studies have suggested the antibody response fades within months following COVID infection. T Cell immunity on the other hand can stay for years, and it may be the effectiveness of creating a T cell immunity that dictates just how good this vaccine will be .

Read Blog

Monthly Field Day with Patients & Staff: Building Trust, Engagement, and Wellbeing

Healthcare is built on relationships. While diagnosis, treatment and technology are critical, the human connection between patients and healthcare staff remains central to healing and recovery. A Monthly Field Day with Patients & Staff is a thoughtful initiative designed to strengthen these relationships by creating opportunities for interaction outside routine clinical environments.

In today’s healthcare systems, patient engagement and staff wellbeing are recognised as essential components of quality care. Monthly field days provide a structured yet informal platform to support both.

What Is a Monthly Field Day with Patients & Staff?

A Monthly Field Day is a planned engagement event where patients and healthcare staff come together to participate in non-clinical activities. These events focus on:

interaction
wellbeing
communication
community-building

They are not medical appointments but shared experiences that promote trust and understanding.

Why Field Days Matter in Healthcare

Healthcare Is Emotionally Demanding

Patients often experience anxiety, fear and uncertainty. Staff face long hours, emotional stress and high responsibility. Field days offer a space for:

relaxed interaction
emotional connection
mutual understanding

This humanises care delivery.

Strengthening Patient–Staff Trust

Trust grows through:

open communication
shared experiences
consistent engagement

Field days reduce perceived barriers between patients and healthcare teams.

Benefits for Patients

Improved Comfort and Confidence

Patients feel more at ease when they know the people involved in their care beyond clinical roles.

Better Engagement in Care

Engaged patients are more likely to:

ask questions
follow care plans
attend follow-ups

This leads to improved health outcomes.

Emotional and Social Wellbeing

Social interaction, light activity and positive experiences support mental and emotional health, especially for patients with chronic conditions.

Benefits for Healthcare Staff

Reduced Burnout

Regular non-clinical engagement helps:

reduce emotional fatigue
restore motivation
improve job satisfaction

Stronger Team Relationships

Shared activities strengthen teamwork and communication among staff members.

Renewed Sense of Purpose

Seeing patients outside stressful clinical settings reinforces the meaningful impact of healthcare work.

Organisational Benefits

Enhanced Patient-Centered Culture

Field days reinforce values of empathy, accessibility and respect.

Improved Patient Satisfaction

Trust and familiarity contribute to better patient experiences and feedback.

Better Communication and Feedback

Informal settings encourage honest dialogue, helping organisations understand patient needs and expectations.

Activities Commonly Included in Field Days

Wellness Activities

gentle exercises
stretching or yoga
breathing sessions

Educational Interactions

health awareness talks
preventive care discussions
lifestyle guidance

Recreational and Social Activities

group games
creative sessions
interactive challenges

These activities promote joy, connection and inclusion.

Inclusivity and Accessibility

Effective field days are:

inclusive of different age groups
adaptable for physical limitations
culturally sensitive
welcoming and non-competitive

Inclusivity ensures meaningful participation for all.

Why Monthly Frequency Works Best

Monthly scheduling:

maintains continuity
builds long-term trust
prevents disengagement
supports gradual relationship building

Consistency transforms engagement into culture.

Evidence Supporting Engagement Initiatives

Research shows that:

patient engagement improves health outcomes
staff wellbeing reduces errors and burnout
relationship-based care enhances satisfaction

Global health frameworks emphasise people-centred care models.

Measuring the Impact of Field Days

Impact can be evaluated through:

patient feedback
staff engagement surveys
participation rates
qualitative testimonials

Regular assessment helps refine the program.

Implementing a Successful Monthly Field Day

Key elements include:

leadership support
clear objectives
simple, inclusive activities
consistent scheduling
feedback-driven improvement

Success depends on commitment rather than scale.

Long-Term Impact on Healthcare Culture

Over time, Monthly Field Days contribute to:

stronger trust
improved communication
better morale
enhanced care experience

They reinforce the idea that healthcare is a partnership between people.

Conclusion

A Monthly Field Day with Patients & Staff is more than an engagement activity—it is a meaningful investment in trust, wellbeing and human connection. By creating shared experiences beyond clinical settings, healthcare organisations strengthen relationships that directly influence care quality and satisfaction. In an environment often driven by efficiency and outcomes, monthly field days remind us that compassion, communication and community remain at the heart of effective healthcare.

References

World Health Organization (WHO) – People-Centred Care and Patient Engagement
Indian Council of Medical Research (ICMR) – Patient Experience and Care Quality Studie
Lancet – Patient–Provider Relationships and Health Outcomes
National Health Systems Resource Centre – Community Engagement in Healthcare
Indian Journal of Healthcare Management – Staff Wellbeing and Patient Satisfaction
Statista – Healthcare Engagement and Experience Trends

Request A Callback

+91

By using this website/app, I confirm that I am at least 18 years old and consent to the processing of my personal data in accordance with the Terms of Service, Privacy Policy, and Declaration.